| Initial public offering of up to 11,600,000 equity shares of face value of Rs. 10 each ("Equity shares") of Dr. Lal Pathlabs Limited (The "Company" or The "Issuer") for cash at a price of Rs. 550 per equity share including a share premium of Rs. 540 per equity share (The "Offer Price"), aggregating Rs. 631.91 crores (The "Offer") through an offer for sale of 1,261,996 equity shares aggregating Rs. 68.75 crores by (Hony.) Brig. Dr. Arvind Lal, 2,056,747 equity shares aggregating Rs. 112.04 crores by Dr. Vandana Lal, 238,226 equity shares aggregating Rs. 12.98 crores by Eskay House (HUF), 550,386 equity shares aggregating Rs. 29.98 crores by Mr. Anjaneya Lal (collectively, the "promoter selling shareholders" and such equity shares being the "promoter offered shares"), 5,860,000 equity shares aggregating Rs. 319.22 crores by Wagner Limited, 1,471,575 equity shares aggregating Rs. 80.16 crores by Westbridge Crossover Fund, LLC, 161,070 equity shares aggregating Rs. 8.77 crores by Sanjeevini Investment Holdings (collectively, the "investor selling shareholders" and such equity shares being the "investor offered shares", and with the promoter selling shareholders, the "selling shareholders") (The "offer for sale"). The offer shall constitute 14.04% of the post-offer paid-up equity share capital of the company.
The face value of the equity share is Rs. 10 each and the offer price is 55 times of the face value of the equity shares.
The Face value of the equity share is Rs. 10 each.
|